(Excerpt from Report #G125, Products, Technologies, Markets and Opportunities in Ophthalmology Surgical, Device and Drug Markets Worldwide, 2007.)
Although there is a broad spectrum of medical technology innovations taking place in the ophthalmology sector, pharmaceuticals will continue to be a critical component of both elective and emergency ocular interventions. As a result, the dominant players in the pharmaceutical sector will realize strong growth, particularly in the areas of Dry Eye management (as a result of complications following refractive surgery), Glaucoma medications and treatments for wet AMD.
Below is a forecast of the European ophthalmic pharmaceuticals market by segment.
The market in Europe for ophthalmic pharmaceuticals is dominated by Alcon, with Pfizer showing a distant second.
The report #G125 on the worldwide ophthalmic products market is available for purchase and immediate download at link.
